Your browser doesn't support javascript.
loading
Increase over time of antibody levels 3 months after a booster dose as an indication of better protection against Omicron infection.
Bingula, Rea; Chabrolles, Hélène; Bonnet, Benjamin; Archimbaud, Christine; Brebion, Amélie; Cosme, Justine; Ollier, Amandine; Dutheil, Frédéric; Junda, Maud; Mirand, Audrey; Regagnon, Christel; Vidal, Magali; Henquell, Cécile; Evrard, Bertrand.
Afiliación
  • Bingula R; UMR UNH, ECREIN, Immunology Laboratory, Faculty of Medicine, Clermont Auvergne University, Clermont-Ferrand, France.
  • Chabrolles H; Virology Department, Clermont-Ferrand University Hospital (CHU Clermont-Ferrand), 3IHP, Clermont-Ferrand, France.
  • Bonnet B; CNRS UMR 6023, LMGE, Clermont Auvergne University, Clermont-Ferrand, France.
  • Archimbaud C; UMR UNH, ECREIN, Immunology Laboratory, Faculty of Medicine, Clermont Auvergne University, Clermont-Ferrand, France.
  • Brebion A; Immunology Department, Clermont-Ferrand University Hospital (CHU Clermont Ferrand), Clermont-Ferrand, France.
  • Cosme J; Virology Department, Clermont-Ferrand University Hospital (CHU Clermont-Ferrand), 3IHP, Clermont-Ferrand, France.
  • Ollier A; CNRS UMR 6023, LMGE, Clermont Auvergne University, Clermont-Ferrand, France.
  • Dutheil F; Virology Department, Clermont-Ferrand University Hospital (CHU Clermont-Ferrand), 3IHP, Clermont-Ferrand, France.
  • Junda M; Immunology Department, Clermont-Ferrand University Hospital (CHU Clermont Ferrand), Clermont-Ferrand, France.
  • Mirand A; Clinical Research and Innovation Direction, Clermont-Ferrand University Hospital (CHU Clermont-Ferrand) 3 IHP, Clermont-Ferrand, France.
  • Regagnon C; Preventive and Occupational Medicine, Clermont-Ferrand University Hospital (CHU Clermont-Ferrand), Clermont-Ferrand, France.
  • Vidal M; CNRS, LaPSCo Physiological and Psychosocial Stress, Clermont Auvergne University, Clermont-Ferrand, France.
  • Henquell C; Immunology Department, Clermont-Ferrand University Hospital (CHU Clermont Ferrand), Clermont-Ferrand, France.
  • Evrard B; Virology Department, Clermont-Ferrand University Hospital (CHU Clermont-Ferrand), 3IHP, Clermont-Ferrand, France.
Emerg Microbes Infect ; 12(1): 2184176, 2023 Dec.
Article en En | MEDLINE | ID: mdl-36848040
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 / Vacuna BNT162 Límite: Humans Idioma: En Revista: Emerg Microbes Infect Año: 2023 Tipo del documento: Article País de afiliación: Francia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 / Vacuna BNT162 Límite: Humans Idioma: En Revista: Emerg Microbes Infect Año: 2023 Tipo del documento: Article País de afiliación: Francia